Dr. Bray Links

Tuesday, September 11, 2018

Report: Pharma exec says he had 'moral requirement' to raise drug price 400% - CNN

Nirmal Mulye, founder and president of Nostrum Pharmaceuticals, commented in a story Tuesday about the decision to raise the price of an antibiotic mixture called nitrofurantoin from about $500 per bottle to more than $2,300. The drug is listed by the World Health Organization as an "essential" medicine for lower urinary tract infections.

"I think it is a moral requirement to make money when you can," Mulye told the Financial Times, "to sell the product for the highest price."

The Financial Times said Mulye compared his decision to increase the price to that of an art dealer who sells "a painting for half a billion dollars" and said he was in "this business to make money." 

https://amp.cnn.com/cnn/2018/09/11/health/drug-price-hike-moral-requirement-bn/index.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.